The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
We can do more in pursuing a zero-waste strategy in relation to sought-after COVID-19 vaccines.
There are three measures for assessing whether public policy is successful, and the Coalition has been found wanting on all three. But there’s one policy area that’s an even bigger disaster.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Inconsistency, uncertainty and confusion are leading to vaccination delays.
Supply isn’t the problem with the COVID-19 vaccination rollout – it’s the structural and communications issues that need addressing.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
COVID-19 vaccine tourism has swiftly evolved into a thriving global industry as people look to secure a quick vaccination fix.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
Dummy text
